ClinicalTrials.gov
public full text
Public Domain
Intravenous (IV) Lidocaine for Opioid-refractory Pain
Opioid medicines, like morphine, are the main treatment for severe cancer pain. Unfortunately, some patients suffer severe pain despite high doses of opioids. We hypothesize that intravenous lidocaine can quickly and effectively treat this kind of opioid-refractory pain.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Intravenous Lidocaine for Perioperative and Postoperative Analgesia#1292880
- Intranasal Fentanyl for the Treatment of Breakthrough Pain in Cancer Patients (FT-017-IM)#1262242
- An Interventional Study for Patient With Cancer Pain to Evaluate the Efficacy and Safety of OxyNorm® Compared to Morphine Sulfate Through the IV Continuous Infusion.#875351
- Nasal Fentanyl for Patient Controlled Treatment of Pain in Cancer#1058101
- Intravenous Lidocaine and Ketorolac for Pain Management#1281750
Record · ID 1231209
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive